Abstract

Surface modification with the plasma of the direct current reactive magnetron sputtering has demonstrated its efficacy as a tool for enhancing the biocompatibility of polymeric electrospun scaffolds. Improvement of the surface wettability of materials with water, as well as the formation of active chemical bonds in the near-surface layers, are the main reasons for the described effect. These surface effects are also known to increase the release rate of drugs incorporated in fibers. Herein, we investigated the effect of plasma modification on the chloramphenicol release from electrospun poly (lactic acid) fibrous scaffolds. Scaffolds with high—50 wt./wt.%—drug content were obtained. It was shown that plasma modification leads to an increase in the drug release rate and drug diffusion coefficient, while not deteriorating surface morphology and mechanical properties of scaffolds. The materials’ antibacterial activity was observed to increase in the first day of the experiment, while remaining on the same level as the unmodified group during the next six days. The proposed technique for modifying the surface of scaffolds will be useful for obtaining drug delivery systems with controlled accelerated release, which can expand the possibilities of local applications of antibiotics and other drugs.

Highlights

  • Surgical site infections (SSIs) are one of the serious threats associated with the installation of implants during surgery

  • The proposed technique for modifying the surface of scaffolds will be useful for obtaining drug delivery systems with controlled accelerated release, which can expand the possibilities of local applications of antibiotics and other drugs

  • It has been shown that DC reactive magnetron plasma modification leads to burst drug release from the fibers

Read more

Summary

Introduction

Surgical site infections (SSIs) are one of the serious threats associated with the installation of implants during surgery. [1] These kinds of bacteria can form harmful and toxic biofilms on the surface of implants [2]. Biofilms form on the surface of the implant or at the interface between living tissue and dead bone, preventing the bone healing process. Subpopulations of bacteria in the biofilm can differentiate into a phenotypically stable state and form biofilm-specific antimicrobial resistant genes, which significantly reduces the effectiveness of antibiotic therapy [2]. The combination of these factors can further lead to the rejection of the implant by the body, sepsis, and the need for reoperation [2]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call